Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis

AUTOR(ES)

Molinari, Marta

FONTE

Oxford University Press

RESUMO

The Cdc25 A phosphatase is required for the G1–S transition of the cell cycle and is overexpressed in human cancers. We found that it is ubiquitylated and rapidly degraded by the proteasome and that its levels increase from G1 until mitosis. By treating cells with the DNA synthesis inhibitor hydroxyurea, Cdc25 A rapidly decreased in abundance, and this was accompanied by an increase in Cdk2 phosphotyrosine content and a decrease in Cdk2 kinase activity. Cdc25 A overexpression altered the ability of cells to arrest in the presence of hydroxyurea, and caused them to undergo premature chromosome condensation. Cdc25 A overexpression could render tumor cells less sensitive to DNA replication checkpoints, thereby contributing to their genomic instability.

Documentos Relacionados

• In vitro reconstitution of cdc25 regulated S. cerevisiae adenylyl cyclase and its kinetic properties.
• Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.
• Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity.
• Phosphorylation and activation of human cdc25-C by cdc2--cyclin B and its involvement in the self-amplification of MPF at mitosis.
• SDC25, a dispensable Ras guanine nucleotide exchange factor of Saccharomyces cerevisiae differs from CDC25 by its regulation.